Publications

Export 1755 results:
Auteur [ Title(Desc)] Type Année
Filtres: First Letter Of Last Name is M  [Enlever les filtres]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Makowski C, Bodnar M, Malla AK, Joober R, Lepage M.  2016.  Age-related cortical thickness trajectories in first episode psychosis patients presenting with early persistent negative symptoms.. NPJ Schizophr. 2:16029.
Makowski C, Bodnar M, Malla AK, Joober R, Lepage M.  2016.  Age-related cortical thickness trajectories in first episode psychosis patients presenting with early persistent negative symptoms.. NPJ Schizophr. 2:16029.
Maillet D, Maria Rajah N.  2014.  Age-related differences in brain activity in the subsequent memory paradigm: a meta-analysis.. Neurosci Biobehav Rev. 45:246-57.
Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG et al..  2015.  Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.. Int Psychogeriatr. 27(1):7-17.
Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR et al..  2019.  Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists.. Sci Signal. 12(574)
Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR et al..  2019.  Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists.. Sci Signal. 12(574)
Forest M, O'Donnell K, Voisin G, Gaudreau H, MacIsaac JL, McEwen LM, Silveira PP, Steiner M, Kobor MS, Meaney MJ et al..  2018.  Agreement in DNA methylation levels from the Illumina 450K array across batches, tissues, and time.. Epigenetics. 13(1):19-32.
Forest M, O'Donnell K, Voisin G, Gaudreau H, MacIsaac JL, McEwen LM, Silveira PP, Steiner M, Kobor MS, Meaney MJ et al..  2018.  Agreement in DNA methylation levels from the Illumina 450K array across batches, tissues, and time.. Epigenetics. 13(1):19-32.
Forest M, O'Donnell K, Voisin G, Gaudreau H, MacIsaac JL, McEwen LM, Silveira PP, Steiner M, Kobor MS, Meaney MJ et al..  2018.  Agreement in DNA methylation levels from the Illumina 450K array across batches, tissues, and time.. Epigenetics. 13(1):19-32.
Mankiw C, Park MTae M, Reardon PK, Fish AM, Clasen LS, Greenstein D, Giedd JN, Blumenthal JD, Lerch JP, M Chakravarty M et al..  2017.  Allometric Analysis Detects Brain Size-Independent Effects of Sex and Sex Chromosome Complement on Human Cerebellar Organization.. J Neurosci. 37(21):5221-5231.
Picard C, Julien C, Frappier J, Miron J, Théroux L, Dea D, Breitner JCS, Poirier J.  2018.  Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease.. Neurobiol Aging. 66:180.e1-180.e9.
Barde S, Rüegg J, Prud'homme J, Ekström TJ, Palkovits M, Turecki G, Bagdy G, Ihnatko R, Theodorsson E, Juhasz G et al..  2016.  Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide.. Proc Natl Acad Sci U S A. 113(52):E8472-E8481.
Cheong CY, Chng K, Lim MKee, Amrithraj AI, Joseph R, Sukarieh R, Tan YChee, Chan L, Tan JHao, Chen L et al..  2014.  Alterations to DNA methylation and expression of CXCL14 are associated with suboptimal birth outcomes.. J Hum Genet. 59(9):504-11.
Luck D, Joober R, Malla A, Lepage M.  2016.  Altered emotional modulation of associative memory in first episode schizophrenia: An fMRI study.. Schizophr Res Cogn. 3:26-32.
Barucker C, Sommer A, Beckmann G, Eravci M, Harmeier A, Schipke CG, Brockschnieder D, Dyrks T, Althoff V, Fraser PE et al..  2015.  Alzheimer amyloid peptide aβ42 regulates gene expression of transcription and growth factors.. J Alzheimers Dis. 44(2):613-24.
Mondragon-Rodriguez S, Gu N, Manseau F, Williams S.  2018.  Alzheimer's Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition.. Front Cell Neurosci. 12:121.
Mondragon-Rodriguez S, Gu N, Manseau F, Williams S.  2018.  Alzheimer's Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition.. Front Cell Neurosci. 12:121.
Menear M, Gilbert M, MJ Fleury.  2017.  Améliorer la santé mentale des populations par l’intégration des soins de santé mentale aux soins primaires. 42(1):243-271.
Caravaggio F, Fervaha G, Iwata Y, Plitman E, Chung JKu, Nakajima S, Mar W, Gerretsen P, Kim J, M Chakravarty M et al..  2018.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.. Int J Geriatr Psychiatry. 33(3):523-530.
Caravaggio F, Fervaha G, Iwata Y, Plitman E, Chung JKu, Nakajima S, Mar W, Gerretsen P, Kim J, M Chakravarty M et al..  2018.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.. Int J Geriatr Psychiatry. 33(3):523-530.
Caravaggio F, Fervaha G, Iwata Y, Plitman E, Chung JKu, Nakajima S, Mar W, Gerretsen P, Kim J, M Chakravarty M et al..  2018.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.. Int J Geriatr Psychiatry. 33(3):523-530.
Reynolds LM, Makowski CS, Yogendran SV, Kiessling S, Cermakian N, Flores C.  2015.  Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent manner.. Neuropsychopharmacology. 40(5):1101-12.
Pascoal TA, Mathotaarachchi S, Shin M, Park AYeon, Mohades S, Benedet AL, Kang MSu, Massarweh G, Soucy J-P, Gauthier S et al..  2018.  Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 45(6):1021-1030.
Pascoal TA, Mathotaarachchi S, Shin M, Park AYeon, Mohades S, Benedet AL, Kang MSu, Massarweh G, Soucy J-P, Gauthier S et al..  2018.  Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 45(6):1021-1030.
Pascoal TA, Mathotaarachchi S, Shin M, Park AYeon, Mohades S, Benedet AL, Kang MSu, Massarweh G, Soucy J-P, Gauthier S et al..  2018.  Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 45(6):1021-1030.

Pages